• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外受精中的不良反应者:预后总是很差吗?:一项系统评价。

The poor responder in IVF: is the prognosis always poor?: a systematic review.

机构信息

Department of Reproductive Medicine and Gynaecology, University Medical Center Utrecht, GA Utrecht, The Netherlands.

出版信息

Hum Reprod Update. 2012 Jan-Feb;18(1):1-11. doi: 10.1093/humupd/dmr037. Epub 2011 Oct 10.

DOI:10.1093/humupd/dmr037
PMID:21987525
Abstract

BACKGROUND In IVF treatment a considerable proportion of women are faced with a low number of oocytes retrieved. These poor responders have reduced pregnancy rates compared with normal responders. However, this may not be applicable to all poor responders. This review aims at identifying patient characteristics and ovarian reserve tests (ORT) that will determine prognosis for pregnancy in poor responders. METHODS A systematic search was conducted in PubMed, Embase, Cochrane and SCOPUS databases in April 2010. Studies regarding patient characteristics or ORT in poor responders and their pregnancy prospects were included. All included papers were summarized in descriptive tables. RESULTS Nineteen studies were included. Pooled data of six studies comparing poor and normal responders demonstrated clearly lower pregnancy rates in poor responders (14.8 versus 34.5%). Ten studies indicated that older poor responders have a lower range of pregnancy rates compared with younger (1.5-12.7 versus 13.0-35%, respectively). Four studies showed that pregnancy prospects become reduced when fewer oocytes are retrieved (0-7% with 1 oocyte versus 11.5-18.6% with 4 oocytes). Five studies concerning pregnancy rates in subsequent cycles suggested a more favourable outcome in unexpected poor responders, and if ≥2 oocytes were retrieved. CONCLUSIONS Poor responders are not a homogeneous group of women with regards to pregnancy prospects. Female age and number of oocytes retrieved in particular will modulate the chances for pregnancy in current and subsequent cycles. Applying these criteria will allow the identification of couples with a reasonable prognosis and balanced decision-making on the management of poor responders.

摘要

背景

在体外受精(IVF)治疗中,相当一部分女性面临着取出的卵子数量较少的问题。这些反应不良的患者与正常反应的患者相比,怀孕率降低。然而,这可能并不适用于所有反应不良的患者。本综述旨在确定患者特征和卵巢储备测试(ORT),以确定反应不良患者的妊娠预后。

方法

2010 年 4 月,我们在 PubMed、Embase、Cochrane 和 SCOPUS 数据库中进行了系统检索。纳入了关于反应不良患者的患者特征或 ORT 及其妊娠前景的研究。所有纳入的文献均在描述性表格中进行了总结。

结果

纳入了 19 项研究。六项研究的汇总数据表明,反应不良组的妊娠率明显低于正常反应组(14.8%比 34.5%)。十项研究表明,年龄较大的反应不良患者的妊娠率范围低于年龄较小的患者(分别为 1.5%-12.7%比 13.0%-35%)。四项研究表明,随着取卵数的减少,妊娠前景也会下降(1 个卵时为 0%-7%,4 个卵时为 11.5%-18.6%)。五项关于后续周期妊娠率的研究表明,在意外反应不良的患者中,如果取出≥2 个卵,后续周期的结局更为有利。

结论

反应不良的患者在妊娠前景方面并不是一个同质的群体。女性年龄和取出的卵子数量尤其会影响当前和后续周期的妊娠机会。应用这些标准将有助于识别具有合理预后的夫妇,并在反应不良患者的管理方面做出平衡的决策。

相似文献

1
The poor responder in IVF: is the prognosis always poor?: a systematic review.体外受精中的不良反应者:预后总是很差吗?:一项系统评价。
Hum Reprod Update. 2012 Jan-Feb;18(1):1-11. doi: 10.1093/humupd/dmr037. Epub 2011 Oct 10.
2
Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).针对接受体外受精加卵胞浆内单精子注射(IVF/ICSI)的女性,使用卵巢储备标志物进行个性化促性腺激素剂量选择。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012693. doi: 10.1002/14651858.CD012693.pub2.
3
Growth hormone for in vitro fertilisation (IVF).促性腺激素在体外受精(IVF)中的应用。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD000099. doi: 10.1002/14651858.CD000099.pub4.
4
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
5
Volume expanders for the prevention of ovarian hyperstimulation syndrome.用于预防卵巢过度刺激综合征的扩容剂。
Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001302. doi: 10.1002/14651858.CD001302.pub3.
6
Intra-cytoplasmic sperm injection versus partial zona dissection, subzonal insemination and conventional techniques for oocyte insemination during in vitro fertilisation.体外受精过程中卵母细胞受精的胞浆内单精子注射与部分透明带切除术、透明带下授精及传统技术的比较
Cochrane Database Syst Rev. 2000(2):CD001301. doi: 10.1002/14651858.CD001301.
7
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5.
8
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
9
Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.重组促黄体生成素(rLH)和重组促卵泡生成素(rFSH)用于体外受精/卵胞浆内单精子注射周期中的卵巢刺激。
Cochrane Database Syst Rev. 2017 May 24;5(5):CD005070. doi: 10.1002/14651858.CD005070.pub3.
10
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).辅助生殖(体外受精和卵胞浆内单精子注射)中刺激周期的监测。
Cochrane Database Syst Rev. 2008 Apr 16(2):CD005289. doi: 10.1002/14651858.CD005289.pub2.

引用本文的文献

1
The Type of Follicle-Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta-Analysis.用于体外受精的促卵泡激素药物类型对卵母细胞采集的影响:一项系统评价和荟萃分析。
Clin Pharmacol Ther. 2025 Oct;118(4):790-802. doi: 10.1002/cpt.70014. Epub 2025 Jul 31.
2
Non-targeted metabolomic analysis of follicular fluid in infertile individuals with poor ovarian response.卵巢反应不良的不孕个体卵泡液的非靶向代谢组学分析
Front Endocrinol (Lausanne). 2025 May 12;16:1547550. doi: 10.3389/fendo.2025.1547550. eCollection 2025.
3
Unraveling the Clinical FSH Conundrum: Insights From the Small Ovarian Reserve Heifer Model.
解开临床促卵泡生成素难题:来自小卵巢储备小母牛模型的见解。
Mol Reprod Dev. 2025 Feb;92(2):e70007. doi: 10.1002/mrd.70007.
4
Development and validation of a nomogram for failure to collect oocytes in POSEIDON Groups 3 and 4 undergoing IVF/ICSI treatment.用于预测接受体外受精/卵胞浆内单精子注射治疗的波塞冬3组和4组中未采集到卵母细胞的列线图的开发与验证
Sci Rep. 2024 Dec 28;14(1):31316. doi: 10.1038/s41598-024-82783-z.
5
Could the use of agonist protocols benefit patients who do not respond well to human reproduction treatment?激动剂方案的使用能否使对人类生殖治疗反应不佳的患者受益?
JBRA Assist Reprod. 2024 Dec 2;28(4):624-628. doi: 10.5935/1518-0557.20240057.
6
Analysis of single-cell RNA sequencing in human oocytes with diminished ovarian reserve uncovers mitochondrial dysregulation and translation deficiency.分析卵巢储备功能降低的人类卵母细胞的单细胞 RNA 测序,揭示了线粒体功能紊乱和翻译缺陷。
Reprod Biol Endocrinol. 2024 Nov 15;22(1):146. doi: 10.1186/s12958-024-01321-8.
7
Association of sleep disturbances with diminished ovarian reserve in women undergoing infertility treatment.睡眠障碍与接受不孕治疗的女性卵巢储备功能降低有关。
Sci Rep. 2024 Nov 1;14(1):26279. doi: 10.1038/s41598-024-78123-w.
8
Oocyte Competence, Embryological Outcomes and miRNA Signature of Different Sized Follicles from Poor Responder Patients.不同大小卵泡对卵巢低反应患者卵母细胞成熟度、胚胎发育结局及 miRNA 特征的影响。
Int J Mol Sci. 2024 Sep 24;25(19):10237. doi: 10.3390/ijms251910237.
9
Regulation of glucose metabolism: Effects on oocyte, preimplantation embryo, assisted reproductive technology and embryonic stem cell.葡萄糖代谢的调节:对卵母细胞、植入前胚胎、辅助生殖技术及胚胎干细胞的影响
Heliyon. 2024 Sep 28;10(19):e38551. doi: 10.1016/j.heliyon.2024.e38551. eCollection 2024 Oct 15.
10
Efficacy and safety of Shen Que (RN8) moxibustion on reproductive outcomes in unexpected poor ovarian responders: a randomized controlled trial.神阙穴(RN8)艾灸对不明原因卵巢低反应患者妊娠结局的疗效和安全性:一项随机对照试验。
J Ovarian Res. 2024 Aug 29;17(1):177. doi: 10.1186/s13048-024-01493-2.